PRODUCTION OF INTERLEUKIN-6, TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-10 IN-VITRO CORRELATES WITH THE CLINICAL IMMUNE DEFECT IN CHRONIC-HEMODIALYSIS PATIENTS
M. Girndt et al., PRODUCTION OF INTERLEUKIN-6, TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-10 IN-VITRO CORRELATES WITH THE CLINICAL IMMUNE DEFECT IN CHRONIC-HEMODIALYSIS PATIENTS, Kidney international, 47(2), 1995, pp. 559-565
In patients with chronic renal failure alterations in monokine product
ion are a common feature. Their clinical relevance has not yet been pr
oven. We show here a correlation between an overproduction of interleu
kin- (IL)-6 and tumor necrosis factor alpha (TNF alpha) upon stimulati
on with LPS by mononuclear cells in vitro and the clinical grade of im
munodeficiency found in these patients. Higher levels of IL-6 and TNF
alpha were correlated with an immunocompromized state, that is, non re
sponsiveness to hepatitis B vaccination, whereas patients with a batte
r immune competence showed the same levels of these cytokines as healt
hy controls. Only the patients with a good immune function showed a hi
gh secretion of IL-10. The feedback mechanism of IL-10 for reducing mo
nokine synthesis seems to be intact in these patients. Thus the secret
ion of IL-10 might be regarded as a compensatory mechanism which contr
ols monokine induction by chronic renal failure and hemodialysis treat
ment. Immunocompromized patients who are unresponsive to hepatitis B v
accination seem to be unable to enhance IL-10 synthesis for control of
monokine overproduction. This results in higher levels of IL-6 and TN
F alpha that might be involved in the pathogenesis of reduced immune d
efense.